| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |